Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Unichem Laboratories Ltd. Director's Dealing 2023

Aug 2, 2023

61109_rns_2023-08-02_fb4cb2d5-4f56-4946-9561-1872c87d3538.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Dr. Prakash Mody

Residence: 2/C, Woodlands, 67, Dr. G.D. Marg, Mumbai - 400 026. Tel.: 2353 6940

August 2, 2023

BSE Ltd. National Stock Exchange India Limited, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block-G, Dalal Street Bandra Kurla Complex, Mumbai 400 023 Bandra – (East). Mumbai-400051. Scrip Code : 506690 Scrip Code: UNICHEMLAB

Subject: Disclosure of dealing in shares of Unichem Laboratories Limited in terms of Regulations 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

This is to inform you that I, Dr. Prakash A. Mody, (Dr. Mody), promoter of the Company have sold and transferred 2,35,01,440 fully paid-up equity shares of Rs. 2/- each, constituting 33.38% of the fully diluted voting share capital of the Company to Ipca Laboratories Limited (Ipca) pursuant to the Share Purchase agreement dated 24th April 2023 entered into between me, Ipca and the Company.

In compliance with the provisions of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find enclosed a copy of the disclosure of dealing in shares of the Company.

Kindly take the above in your records and oblige.

Yours faithfully,

Digitally signed by Prakash Prakash Amrut Mody Amrut Mody Date: 2023.08.02 15:40:39 +05'30' ______ Dr. Prakash A. Mody Promoter

CC to

Head – Legal & Company Secretary Unichem Laboratories Limited Unichem Bhavan, Prabhat Estate, Off S.V. Road, Jogeshwari (W) Mumbai 400 102

Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Name of the Target Company (TC) Name of the Target Company (TC) Unichem Laboratories Limited Unichem Laboratories Limited Unichem Laboratories Limited
Name(s) of the Seller~~/acquirer~~and Persons Acting in Concert
(PAC)with the acquirer
Dr. Prakash A. Mody
Whether the Seller/a ~~cquirer~~belongs to Promoter/Promoter group Yes
Name(s) of the Stock Exchange(s) where the shares of TC are
Listed
BSE Limited
National Stock Exchange of India Limited
Details of the acquisition / disposal as follows Number % w.r.t.total
share/voting
capital
wherever
applicable(*)
% w.r.t. total
diluted share/
voting capital of
the TC (**)
Before the sale~~/acquisition u~~nder consideration, holding of :
a) Shares carrying voting rights
b) Shares in the nature of encumbrance (pledge/ lien/
non-disposal undertaking/ others)
c) Voting rights (VR) otherwise than by shares
d) Warrants/convertible securities/any other instrument
that entitles the acquirer to receive shares carrying
voting rights in the T C (specify holding in each
category)
e) Total (a+b+c+d)
3,24,99,392
-
-
-
3,24,99,392

46.16%
-
-
-
46.16%
46.16%
-
-
-
46.16%
Details of~~acquisition/s~~ale
a) Shares carrying voting rights acquired/sold
b) VRs acquired /sold otherwise than by shares
c) Warrants/convertible securities/any other instrument
that entitles the acquirer to receive shares carrying
voting rights in the TC (specify holding in each
category) acquired/sold
d) Shares encumbered / invoked/released by the acquirer
e) Total (a+b+c+/-d)
2,35,01,440
-
-
-
2,35,01,440
33.38%
-
-
-
33.38%
33.38%
-
-
-
33.38%
After the~~acquisition/~~sale, holding of:
a) Shares carrying voting rights
b) Shares encumbered with the acquirer
c) VRs otherwise than by shares
d) Warrants/convertible securities/any other instrument
that entitles the acquirer to receive shares carrying
voting rights in the TC (specify holding in each
category) after acquisition
e) Total (a+b+c+d)
89,97,952
-
-
-
89,97,952
12.78%
12.78%
12.78%
12.78%
12.78%
-
-
-
12.78%
12.78%
-
-
-
12.78%
Mode of acquisition / sale (e.g. open market / off-market /
public issue / rights issue / preferential allotment / inter-se
transfer etc).
Through Block Deal Mechanism of the National
Stock Exchange of India Ltd. (NSE)
Date of~~acquisition /~~sale of shares / VR or date of receipt of
intimation of allotment of shares, whichever is applicable
August 2, 2023
Equity share capital / total voting capital of the TC before the
said~~acquisition /~~sale
7,04,05,750 equity shares
of Rs. 2/- each amounting
to Rs.14,08,11,500/-

100 %
100%
Equity share capital/ total voting capital of the TC after the
said~~acquisition /~~sale
7,04,05,750 equity shares
of Rs. 2/- each amounting
to Rs.14,08,11,500/-

100 %
100%
Total diluted share/voting capital of the TC after the said
sale/~~acquisition~~
7,04,05,750 equity shares
of Rs. 2/- each amounting
to Rs.14,08,11,500/-

100 %
100%

(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement.

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

Prakash Digitally signed by Prakash Amrut Mody Date: 2023.08.02 Amrut Mody 15:41:50 +05'30'

_______

Signature of the ~~acquirer /~~ seller ~~/ Authorised Signatory~~

Name : Dr. Prakash A. Mody

Place: Mumbai

Date: August 2, 2023